ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselModerna Switzerland GmbH
Moderna Switzerland GmbH Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Moderna is the development and application of mRNA technology for the treatment and prevention of diseases. The company focuses on researching and developing medicines and therapies based on the mRNA platform to combat various diseases, including rare diseases and individually tailored therapies.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Moderna Switzerland GmbH

Pharmaceutical Industry
✓ Offered5
mRNA medicines
mRNA medicines for the prevention and treatment of diseases; including approved vaccines as well as clinical programs for infectious diseases, oncology and rare conditions.
Vaccines
Vaccines against COVID-19, RSV, as well as other vaccines in development against influenza, norovirus, CMV, EBV, HIV, Lyme disease, Nipah and Mpox.
Oncology therapeutics
Oncology therapeutics for melanoma, NSCLC, bladder cancer, renal cell carcinoma, multiple myeloma and other solid tumors; in some cases through partnerships with Merck and Immatics.
Rare disease therapeutics
Therapeutics for rare diseases such as propionic acidemia, methylmalonic acidemia and cystic fibrosis; several programs are in clinical development.
Research and development of mRNA platforms
Research, design and testing of mRNA within a few days; development of an mRNA platform for rapid identification, construction and testing of new mRNA medicines.
Trust & reputation

ranQ Trust Score of Moderna Switzerland GmbH: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

Moderna Switzerland GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Moderna Switzerland GmbH scores 80.4 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.96.07%
Moderna Switzerland GmbH scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Moderna Switzerland GmbH scores 58.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.16.74%
Qualifications+0.00

Moderna Switzerland GmbH reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

May 28, 2025Media
Biotech-Boom: Auch diese Pharmafirmen haben sich für die Region Basel entschieden
bazonline.ch

Knowledge

No knowledge articles yet

Once Moderna Switzerland GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Moderna Switzerland GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Moderna Switzerland GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Moderna Switzerland GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Peter Merian-Weg 10
4052 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-344.522.989
Founded
2020 · 6 years
Last commercial register change
February 19, 2026
Employees
101 to 500
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    ST
    SHRARE Technology AG
    Basel
    3B
    3T Biosciences Europe GmbH
    Basel
    AG
    AlphaMeld GmbH
    Basel
    LM
    Laevoroc Medical AG
    Basel
    RS
    Regeneron Switzerland GmbH
    Basel
    ST
    Synendos Therapeutics AG
    Basel
    IF
    Institut für molekulare und klinische Ophthalmologie Basel
    Basel
    VT
    Vaderis Therapeutics AG
    Basel